Nemaura Medical, Inc. (NASDAQ: NMRD), a medical device technology Company developing innovative non-invasive wearable diagnostic devices, announced the official launch of BEAT®diabetes, and the availability of proBEAT™, a non-invasive, daily-wear adhesive glucose monitor. The device comes along a proBEAT™ monitor, a first-in-class non-invasive, daily-wear glucose...
Agenus Inc (NASDAQ: AGEN), a clinical-stage immune-oncology company developing innovative therapies for treatment of cancer, announced the grant of a Fast Track designation for investigation of balstilimab [PD-1] in combination with zalifrelimab [CTLA-4] for the treatment of patients with relapsed or refractory metastatic cervical cancer. [caption...
Charlotte’s Web Holdings (OTCQX: CWBHF), a pioneer in hemp-derived CBD products, announced the completion of an audit of its 2019 hemp harvest, which is the primary source of its full spectrum extracts. The Company grows 100 percent of its Hemp in its American facilities located...
The Global Stock markets are currently facing the fallout from wide-spread pandemonium owing to the coronavirus scare. The outbreak has affected trade and services across the globe, with companies having to step back and access the full impact of the situation. However there are some...
Profound Medical Corp (NASDAQ: PROF), a medical technology Company that offers magnetic resonance guided ablation procedures, announced the approval of its TULSA-PRO® system for the ablation of low to intermediate risk organ-confined prostate cancer by Heath Canada. The Company develops innovative, customizable, incision-free and radiation free...
Axcella Health (NASDAQ: AXLA), a biotechnology Company focussed on leveraging the power of Endogenous Metabolic Modulators, announced the issuance of a third EMM-related patent covering an array of EMM compositions, including AXA1125 and AXA1957, the company’s product candidates for non-alcoholic steatohepatitis (NASH). The patent broadens...
Enlivex Therapeutics (NASDAQ: ENLV), a Company focused on developing allogenic therapies for immune system rebalancing, announced positive interim efficacy data from its ongoing Phase Ib clinical trial in patients with severe sepsis. The analysis in based on data collated from 43 patients with severe sepsis,...
dynaCERT (OTCQB: DYFSF), a Company dealing in transportable hydrogen generator aftermarket products, announced the signing of a strategic agreement with MOSOLF group of Europe, which includes collaboration for distributing dynaCERT’s HydraGENä Technology products throughout the European Union. MOSOLF will act as the dealer for Germany...
NexTech AR Solutions (OTCQB: NEXCF), a leader in the fast emerging Augmented Reality Industy, announced the signing of a multi platform deal with Sand Separation Solutions (SSS), a leading heavy equipment rental company in the oil and gas sector. According to a Company statement the...
Foamix Pharmaceuticals (NASDAQ: FOMX), a clinical stage biotechnology company that is focused on creating solutions for the unmet needs in dermatology by developing topical therapies, has announced that it has secured nearly $64 million in financing from Perceptive Advisors and OrbiMed. According to a company...
